Unibest
← Back to patent-cliff list

CAS 156816-52-3

{4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl 4-methylbenzene-1-sulfonate

Codes: Mosapride Citrate-034

Application context (from source-drug indications)

GastritisMosapride CitrateEnteral feeding intoleranceMosapride CitrateIrritable bowel syndromeMosapride CitrateDyspepsiaMosapride CitrateConstipationMosapride Citrate

Source drugs (routes using this intermediate)

DrugTierExpiry
Mosapride CitrateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Mosapride CitrateOptimised routesteps: 10total yield: /
Mosapride CitrateOptimised routesteps: 4total yield: /
[(2R)-4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl phenylmethanesulfonate→(2R)-2-(Phenylmethoxymethyl)oxirane→Sodium (2-aminoethyl) sulfate→2(R)-(Benzyloxymethyl)morpholine→(2R)-morpholin-2-ylmethanol→1-(Chloromethyl)-4-fluorobenzene→{4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl 4-methylbenzene-1-sulfonate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.